Sequana Medical Balance Sheet Health

Financial Health criteria checks 2/6

Sequana Medical has a total shareholder equity of €-19.5M and total debt of €16.8M, which brings its debt-to-equity ratio to -86.2%. Its total assets and total liabilities are €10.1M and €29.6M respectively.

Key information

-86.2%

Debt to equity ratio

€16.79m

Debt

Interest coverage ration/a
Cash€2.58m
Equity-€19.47m
Total liabilities€29.57m
Total assets€10.10m

Recent financial health updates

Recent updates

Health Check: How Prudently Does Sequana Medical (EBR:SEQUA) Use Debt?

Mar 19
Health Check: How Prudently Does Sequana Medical (EBR:SEQUA) Use Debt?

Did Sequana Medical's (EBR:SEQUA) Share Price Deserve to Gain 51%?

Jan 26
Did Sequana Medical's (EBR:SEQUA) Share Price Deserve to Gain 51%?

Do Institutions Own Sequana Medical NV (EBR:SEQUA) Shares?

Dec 03
Do Institutions Own Sequana Medical NV (EBR:SEQUA) Shares?

Financial Position Analysis

Short Term Liabilities: SEQUA has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: SEQUA has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: SEQUA has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: SEQUA's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SEQUA has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: SEQUA is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.